CYTK — Cytokinetics Incorporated price, chart and key statistics

Price data

Price

$65.91

Change YTD

+3.73%

Next earnings

Nov 4, 2026

Market cap

8.7B2016-12 492.3M2026-09 8.7B+1667.7% over the window

Enterprise value

7.4B

Shares outstanding

132.1M2016-06 39.7M2026-06 132.1M+232.7% over the window

52W low

$53.57

52W high

$88.31

From 52W high

-25.37%

From 52W low

+23.04%

52W range

36%

Beta

0.37

Volume

Rel volume

1.49×

30D volume

2M

30D $ vol

141.1M

Fundamentals

Sales (ttm)

67.7M2016-06 31.9M2026-06 67.7M+112.0% over the window

Sales/share

$0.512016-06 $0.802026-06 $0.51-36.3% over the window

EPS (ttm)

-$7.182016-09 $0.002026-06 -$7.18-463463.3% over the window

FCF (ttm)

-580.7M2016-06 -49.7M2026-06 -580.7M+1068.3% over the window

FCF/share

-$4.402016-06 -$1.252026-06 -$4.40+251.2% over the window

Book value/share

-$1.312016-06 $1.232026-06 -$1.31-207.0% over the window

Net margin

-1321.12%2016-06 -132.0%2026-06 -1321.1%+900.8% over the window

ROA

-46.45%2016-06 -39.7%2026-06 -46.5%+17.0% over the window

Current ratio

6.662016-06 3.682026-06 6.66+81.1% over the window

Growth (CAGR, ttm) · 10Y

Sales

-21.09%2025-06-30 → 2026-06-3085.7M → 67.7M (-21.1% total)+89.42%2023-06-30 → 2026-06-3010M → 67.7M (+580.0% total)+3.20%2021-06-30 → 2026-06-3057.8M → 67.7M (+17.1% total)+7.80%2016-06-30 → 2026-06-3031.9M → 67.7M (+112.0% total)

Shares

+10.39%2025-06-30 → 2026-06-30119.7M → 132.1M (+10.4% total)+11.22%2023-06-30 → 2026-06-3096M → 132.1M (+37.6% total)+9.60%2021-06-30 → 2026-06-3083.5M → 132.1M (+58.2% total)+12.77%2016-06-30 → 2026-06-3039.7M → 132.1M (+232.7% total)

Per-share growth (CAGR, ttm) · 10Y

Sales/share

-28.52%2025-06-30 → 2026-06-30$0.72 → $0.51 (-28.5% total)+70.31%2023-06-30 → 2026-06-30$0.10 → $0.51 (+394.2% total)-5.84%2021-06-30 → 2026-06-30$0.69 → $0.51 (-26.0% total)-4.41%2016-06-30 → 2026-06-30$0.80 → $0.51 (-36.3% total)

Price

+19.94%2025-09-30 → 2026-09-30$54.96 → $65.91 (+19.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+30.75%2023-09-29 → 2026-09-30$29.46 → $65.91 (+123.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.02%2021-09-30 → 2026-09-30$35.74 → $65.91 (+84.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+22.10%2016-09-29 → 2026-09-30$8.95 → $65.91 (+636.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

+19.94%2025-09-30 → 2026-09-30$54.96 → $65.91 (+19.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+30.75%2023-09-29 → 2026-09-30$29.46 → $65.91 (+123.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.02%2021-09-30 → 2026-09-30$35.74 → $65.91 (+84.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+22.10%2016-09-29 → 2026-09-30$8.95 → $65.91 (+636.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-9.2×2016-12 7347.472026-09 -9.73-100.1% over the window

Fwd P/E

-14.7×

P/S (ttm)Market cap ÷ TTM revenue.

128.7×2016-12 5.932026-09 128.59+2068.8% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-50.2×2016-12 5.812026-09 -50.16-963.3% over the window

EV/Sales (ttm)

109.5×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-6.67%2016-09 -10.5%2026-06 -5.2%-50.9% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-03-31) ÷ shares_at(2025-03-31) = 1 − 124.4M ÷ 119.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-4.19%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-4.19%) + dividends paid over that year ($0) ÷ market_cap_at(2025-03-31) ($4.8B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-4.19%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-760.1M) ÷ today's market cap ($8.7B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-8.73%2016-09 -1.8%2026-06 -6.8%+283.4% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-760.1M + TTM dividends $0) ÷ today's market cap ($8.7B). Same caveat as the cash buyback yield.

-8.73%2016-09 -1.8%2026-06 -6.8%+283.4% over the window

Vs own 10Y history

P/S

75th

P/B

85th